Contribution of aldehyde dehydrogenase 2 to heart failure development

• Grant number: 12/05765-2
• Support Opportunities: Research Grants - Young Investigators Grants
• Start date: July 01, 2012
• End date: December 31, 2015
• Field of knowledge: Biological Sciences - Physiology - Physiology of Organs and Systems
• Principal Investigator: Julio Cesar Batista Ferreira
• Grantee: Julio Cesar Batista Ferreira
• Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
• Associated scholarship(s): 15/04462-4 - Intracelullar PKCepsilon-ALDH2 axis as a key mechanism in exercise-mediated cardioprotection, BP.MS; 14/15187-1 - Characterization of skeletal muscle satellite cells metabolism and redox balance: role of aldehydes as metabolic sensors, BP.DR; 13/24321-0 - Prior exercise induces cardioprotection against ischemia-reperfusion injury: contribution of the intracellular axis PKCepsilon-ALDH2, BP.IC; 12/19379-7 - Role of ALDH2*2 mutation in heart failure: therapeutic potential of Alda-1, BP.DR

Abstract

The pathophysiology of cardiovascular disease has established that excessive generation and accumulation of aldehydes resulting from oxidative stress are highly cardiotoxic and contribute to the onset and / or aggravation of cardiovascular diseases. Among aldehydes accumulated in the heart, 4-hydroxynonenal (4-HNE), originated from the oxidation of phospholipids present in the inner mitochondrial membrane, has great toxicity to the heart. This electrophilic aldehyde is capable of attacking nucleophilic amino acids and form adducts with proteins (Michaelis adducts), resulting in inactivation of target proteins and consequent cellular dysfunction. The aldehyde dehydrogenase 2 (ALDH2), localized in the mitochondrial matrix, is considered the major enzyme responsible for the elimination of 4-HNE. We have recently found an inverse correlation between ALDH2 activity and the degree of myocardial infarction after cardiac ischemia, where both genetic and pharmacological inhibition of ALDH2 enzyme results in accumulation of 4-HNE and increased myocardial injury. In attempting to assess the therapeutic potential of ALDH2 activation in cardiovascular diseases, we performed a high-throughput screening with 600,000 molecules and identified a small molecule capable of selectively activating ALDH2. This molecule, called Alda-1 was able to keep the ALDH2 enzyme in its active state during the process of cardiac ischemia-reperfusion, minimizing the deleterious effects to the heart. Thus, these results highlight ALDH2 as a key enzyme in the removal of 4-HNE and maintenance of viability during cardiac ischemia-reperfusion, opening a new perspective in the treatment of cardiovascular diseases. In the current proposal, we plan to expand the knowledge regarding the role of ALDH2 in heart failure (HF) development. We will use specific tools developed during my post-doctorate, including the dominant negative transgenic mice for ALDH2, and the small molecule Alda-1, to better understand the ALDH2 contribution to HF progression, as well as the therapeutic potential of Alda-1.HF is a clinical syndrome characterized by cardiac dysfunction associated with exercise intolerance, fluid retention and reduced longevity. The current knowledge regarding the pathophysiology of HF has established that in addition to hemodynamic disturbances and neurohumoral hyper activation, changes in mitochondrial metabolism and redox imbalance contribute to the development of the pathophysiology. Based on this premise, we hypothesized that the mitochondrial dysfunction-mediated ALDH2 inactivation results in the accumulation of 4-HNE, formation of Michaelis adducts, which causes cellular collapse and cardiac dysfunction (see objectives below).This study is interesting and valuable since a better understanding of the role of ALDH2 in HF may contribute for future therapies acting on key mechanisms involved in the pathophysiology of HF, such as the activator of ALDH2 (Alda -1). Moreover, this proposal will bring a new research input for the Department of Anatomy-ICB-USP, including the use of integrative physiology associated with the cellular and molecular biology. Finally, our proposal is deeply supported by outstanding scientists Dr. Daria Mochly-Rosen, Stanford University, CA, USA; Dr. Alicia Kowaltowski Juliana and Dr. Deborah Schechtman, Department of Biochemistry- Chemistry Institute-USP, and Dr. Patricia Chakur Brum, School of Physical Education and Sports-USP. (AU)

Scientific publications

(17)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

CHEN, CHE-HONG; BATISTA FERREIRA, JULIO CESAR; GROSS, ERIC R.; MOCHLY-ROSEN, DARIA. TARGETING ALDEHYDE DEHYDROGENASE 2: NEW THERAPEUTIC OPPORTUNITIES. Physiological Reviews, v. 94, n. 1, p. 1-34, JAN 2014. (12/05765-2)

DISATNIK, MARIE-HELENE; FERREIRA, JULIO C. B.; CAMPOS, JULIANE CRUZ; GOMES, KATIA SAMPAIO; DOURADO, PAULO M. M.; QI, XIN; MOCHLY-ROSEN, DARIA. Acute Inhibition of Excessive Mitochondrial Fission After Myocardial Infarction Prevents Long-term Cardiac Dysfunction. JOURNAL OF THE AMERICAN HEART ASSOCIATION, v. 2, n. 5, OCT 2013. (12/05765-2)

CAMPOS, JULIANE C.; QUELICONI, BRUNO B.; DOURADO, PAULO M. M.; CUNHA, TELMA F.; ZAMBELLI, VANESSA O.; BECHARA, LUIZ R. G.; KOWALTOWSKI, ALICIA J.; BRUM, PATRICIA C.; MOCHLY-ROSEN, DARIA; FERREIRA, JULIO C. B.. Exercise Training Restores Cardiac Protein Quality Control in Heart Failure. PLoS One, v. 7, n. 12, DEC 27 2012. (10/00028-4, 12/05765-2, 09/18546-4, 09/12349-2)

KIYUNA, LIGIA AKEMI; PRESTES E ALBUQUERQUE, RUDA; CHEN, CHE-HONG; MOCHLY-ROSEN, DARIA; BATISTA FERREIRA, JULIO CESAR. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities. Free Radical Biology and Medicine, v. 129, p. 155-168, DEC 2018. (17/16694-2, 17/14426-0, 16/00900-0, 15/22814-5, 15/20783-5, 12/05765-2, 13/07937-8)

CAMPOS, JULIANE CRUZ; FERNANDES, TIAGO; GRASSMANN BECHARA, LUIZ ROBERTO; DA PAIXAO, NATHALIE ALVES; BRUM, PATRICIA CHAKUR; DE OLIVEIRA, EDILAMAR MENEZES; BATISTA FERREIRA, JULIO CESAR. Increased Clearance of Reactive Aldehydes and Damaged Proteins in Hypertension-Induced Compensated Cardiac Hypertrophy: Impact of Exercise Training. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015. (12/05765-2, 06/56321-6)

CAMPOS, JULIANE C.; GOMES, KATIA M. S.; FERREIRA, JULIO C. B.. Impact of exercise training on redox signaling in cardiovascular diseases. Food and Chemical Toxicology, v. 62, p. 107-119, DEC 2013. (12/05765-2, 12/14416-1)

CAMPOS, JULIANE C.; BOZI, LUIZ H. M.; BECHARA, LUIZ R. G.; LIMA, VANESSA M.; FERREIRA, JULIO C. B.. Mitochondrial Quality Control in Cardiac Diseases. FRONTIERS IN PHYSIOLOGY, v. 7, OCT 21 2016. (12/19379-7, 12/14416-1, 15/20783-5, 12/05765-2, 16/01633-5)

FERREIRA, JULIO C. B.; CAMPOS, JULIANE C.; QVIT, NIR; QI, XIN; BOZI, LUIZ H. M.; BECHARA, LUIZ R. G.; LIMA, VANESSA M.; QUELICONI, BRUNO B.; DISATNIK, MARIE-HELENE; DOURADO, PAULO M. M.; et al. A selective inhibitor of mitofusin 1-beta IIPKC association improves heart failure outcome in rats. NATURE COMMUNICATIONS, v. 10, JAN 18 2019. (10/00028-4, 15/22814-5, 17/16694-2, 17/11142-1, 12/05765-2, 10/51906-1, 17/16540-5, 09/12349-2, 16/01633-5, 16/09611-0, 15/20783-5)

GOMES, KATIA M. S.; BECHARA, LUIZ R. G.; LIMA, VANESSA M.; RIBEIRO, MARCIO A. C.; CAMPOS, JULIANE C.; DOURADO, PAULO M.; KOWALTOWSKI, ALICIA J.; MOCHLY-ROSEN, DARIA; FERREIRA, JULIO C. B.. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: Benefits of Alda-1. INTERNATIONAL JOURNAL OF CARDIOLOGY, v. 179, p. 129-138, JAN 20 2015. (12/05765-2, 10/51906-1, 13/07937-8)

GOMES, KATIA M. S.; CAMPOS, JULIANE C.; BECHARA, LUIZ R. G.; QUELICONI, BRUNO; LIMA, VANESSA M.; DISATNIK, MARIE-HELENE; MAGNO, PAULO; CHEN, CHE-HONG; BRUM, PATRICIA C.; KOWALTOWSKI, ALICIA J.; et al. Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. Cardiovascular Research, v. 103, n. 4, p. 498-508, SEP 1 2014. (12/05765-2)

CAMPOS, JULIANE C.; QUELICONI, BRUNO B.; BOZI, LUIZ H. M.; BECHARA, LUIZ R. G.; DOURADO, PAULO M. M.; ANDRES, ALLEN M.; JANNIG, PAULO R.; GOMES, KATIA M. S.; ZAMBELLI, VANESSA O.; ROCHA-RESENDE, CIBELE; et al. Exercise reestablishes autophagic flux and mitochondrial quality control in heart failure. AUTOPHAGY, v. 13, n. 8, p. 1304-1317, 2017. (10/51906-1, 10/00028-4, 09/12349-2, 15/20783-5, 12/05765-2, 16/01633-5)

DISATNIK, MARIE-HELENE; HWANG, SUNHEE; FERREIRA, JULIO C. B.; MOCHLY-ROSEN, DARIA. New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases. JOURNAL OF MOLECULAR MEDICINE-JMM, v. 93, n. 3, p. 279-287, MAR 2015. (12/05765-2)

FERREIRA, JULIO C. B.; MORI, MARCELO A.; GROSS, ERIC R.. Mitochondrial Bioenergetics and Quality Control Mechanisms in Health and Disease. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, v. 2019, p. 3-pg., 2019-01-20. (15/20783-5, 17/07975-8, 17/01184-9, 12/05765-2, 18/18627-3, 17/16694-2)

CAMPOS, JULIANE CRUZ; FERNANDES, TIAGO; GRASSMANN BECHARA, LUIZ ROBERTO; DA PAIXAO, NATHALIE ALVES; BRUM, PATRICIA CHAKUR; DE OLIVEIRA, EDILAMAR MENEZES; BATISTA FERREIRA, JULIO CESAR. Increased Clearance of Reactive Aldehydes and Damaged Proteins in Hypertension-Induced Compensated Cardiac Hypertrophy: Impact of Exercise Training. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, v. 2015, p. 11-pg., 2015-01-01. (06/56321-6, 12/05765-2)

UETA, CINTIA B.; GOMES, KATIA S.; RIBEIRO, MARCIO A.; MOCHLY-ROSEN, DANIA; FERREIRA, JULIO C. B.. Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities. PHARMACOLOGICAL RESEARCH, v. 115, p. 96-106, JAN 2017. (15/01759-6, 13/24321-0, 15/20783-5, 12/05765-2, 14/15187-1)

UETA, CINTIA BAGNE; CAMPOS, JULIANE CRUZ; PRESTES E ALBUQUERQUE, RUDA; LIMA, VANESSA MORAIS; DISATNIK, MARIE-HELENE; SANCHEZ, ANGELICA BIANCHINI; CHEN, CHE-HONG; GENNARI DE MEDEIROS, MARISA HELENA; YANG, WENJIN; MOCHLY-ROSEN, DARIA; et al. Cardioprotection induced by a brief exposure to acetaldehyde: role of aldehyde dehydrogenase 2. Cardiovascular Research, v. 114, n. 7, p. 1006-1015, JUN 1 2018. (12/05765-2, 13/07937-8, 15/20783-5, 13/11315-2)

CUNHA, TELMA F.; BECHARA, LUIZ R. G.; BACURAU, ALINE V. N.; JANNIG, PAULO R.; VOLTARELLI, VANESSA A.; DOURADO, PAULO M.; VASCONCELOS, ANDREA R.; SCAVONE, CRISTOFORO; FERREIRA, JULIO C. B.; BRUM, PATRICIA C.. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats. Journal of Applied Physiology, v. 122, n. 4, p. 817-827, APR 2017. (12/05765-2, 14/23703-0, 11/00728-9)